T-Cell Non-Hodgkin Lymphoma — Trials

T-Cell Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

1,008 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 225
Recruiting: 127
Ph III recruiting: 9
Growth YoY: +23.4%
Industry share: 21%
Top sponsor: Institute of Hematology & Blood Diseases Hospital, China
Termination share: 35.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (169)

clinicaltrialsPublishedShowing 51–100 of 181 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05441761	Mitoxantrone Hydrochloride Liposomes in Combination With GDP in Relapsed/Refractory PTCL	unknown	Phase 1 / Phase 2	60	Peking Union Medical College HospitalOTHER	1	Jul 1, 2022	clinicaltrials
NCT05426824	The Whole-course Management of Pegaspargase in ENKTL	unknown	N/A	72	The First Affiliated Hospital with Nanjing Medical UniversityOTHER	1	Jun 22, 2022	clinicaltrials